U.S. Markets closed

This Biotech Stock Rocketed 80% In Bullish Volume On A Cancer Drug

ALLISON GATLIN
This Biotech Stock Rocketed 80% In Bullish Volume On A Cancer Drug

Deciphera Pharmaceuticals stock nearly doubled Tuesday after the biotech company said its stomach cancer treatment benefited patients who've exhausted at least three other options.